CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Exit or restructuring costs
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Results of operations
Page 5 of 16 · 308 filings